Search Within

Adnan Hasanovic

Formats
  1. Meeting Abstract (9)
  2. Journal Article (4)
Groups
  1. Department of Pathology and Laboratory Medicine (11)
  2. GSK Faculty (11)
  3. Human Oncology and Pathogenesis Program (11)
  4. Tow Center for Developmental Oncology (TCDO) (9)
  5. Department of Medicine (8)
  6. Solid Tumor Oncology Division (8)

More Groups

People
  1. Marc Ladanyi (9)
  2. Lu Wang (7)
  3. Andre Moreira (5)
  4. Alexander Drilon (4)
  5. Mark Kris (4)
  6. Naiyer Rizvi (4)

More People

Years
  1. 2013 (4)
  2. 2012 (7)
  3. 2011 (2)
Publications
  1. Journal of Clinical Oncology (4)
  2. Journal of Molecular Diagnostics (2)
  3. Modern Pathology (2)
  4. Acta Cytologica (1)
  5. Clinical Cancer Research (1)
  6. Histopathology (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (4)
  2. Elsevier Science, Inc. (2)
  3. Nature Research (2)
  4. American Association for Cancer Research (1)
  5. Elsevier Ireland Ltd. (1)
  6. Nature Publishing Group (1)

More Publishers

Results (13)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Patterns of metastasis and survival in patients with PI3K pathway-driven stage IV squamous cell lung cancers (SQCLC)
    Meeting Abstract

    Paik, P. K.; Moreira, A. L.; Wang, L.; Won, H. H.; Hasanovic, A.; Rekhtman, N.; Sima, C. S.; Ladanyi, M.; Berger, M. F.; Kris, M. G.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Screening for RET and ROS1 fusions in an enriched cohort of pan-negative never-smokers with advanced lung adenocarcinomas to identify patients for treatment in targeted therapy trials
    Meeting Abstract

    Drilon, A. E. D.; Wang, L.; Hasanovic, A.; Joubert, P.; Kris, M. G.; Riely, G. J.; Ladanyi, M.; Rizvi, N. A.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • The prevalence of RET and ROS1 gene rearrangements in advanced lung adenocarcinomas pan-negative for other known drivers as revealed by FISH analysis
    Meeting Abstract

    Wang, L.; Islamdoust, N.; Drilon, A. E.; Rizvi, N.; Joubert, P.; Hasanovic, A.; Wynne, M.; Intrieri, J.; Jhanwar, S. C.; Ladanyi, M.
    Journal of Molecular Diagnostics (2013)

    Fulltext@MSK | Save
  • Immunohistochemical staining with EGFR mutation-specific antibodies: High specificity as a diagnostic marker for lung adenocarcinoma
    Journal Article

    Wen, Y. H.; Brogi, E.; Hasanovic, A.; Ladanyi, M.; Soslow, R. A.; Chitale, D.; Shia, J.; Moreira, A. L.
    Modern Pathology (2013)

    Fulltext@MSK | Save
  • KIF5B-RET: Discovery of a novel fusion oncogene in lung adenocarcinomas by a systematic screen for tyrosine kinase fusions and identification of patients for a RET targeted therapy trial
    Meeting Abstract

    Suehara, Y.; Arcila, M. E.; Drilon, A. E. D.; Ito, T.; Wang, L.; Hasanovic, A.; Khanin, R.; Rizvi, N. A.; Ladanyi, M.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Multiplex testing for driver mutations in squamous cell carcinomas of the lung
    Meeting Abstract

    Paik, P. K.; Hasanovic, A.; Wang, L.; Rekhtman, N.; Ladanyi, M.; Kris, M. G.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • The prevalence of FGFR1 amplification in lung squamous cell carcinoma as revealed by FISH analysis
    Meeting Abstract

    Wang, L.; Wang, K.; Islamdoust, N.; Hasanovic, A.; Ladanyi, M.; Jhanwar, S. C.
    Journal of Molecular Diagnostics (2012)

    Fulltext@MSK | Save
  • Identification of KIF5B-RET and GOPC-ROS1 fusions in lung adenocarcinomas through a comprehensive mRNA-based screen for tyrosine kinase fusions
    Journal Article

    Suehara, Y.; Arcila, M.; Wang, L.; Hasanovic, A.; Ang, D.; Ito, T.; Kimura, Y.; Drilon, A.; Guha, U.; Rusch, V.; more...
    Clinical Cancer Research (2012)

    Fulltext@MSK | Save
  • Molecular characterization by immunocytochemistry of lung adenocarcinoma on cytology specimens
    Journal Article

    Moreira, A. L.; Hasanovic, A.
    Acta Cytologica (2012)

    Fulltext@MSK | Save
  • Assessment of EGFR mutation status in carcinomas of the breast, colon, and uterine malignant mixed mullerian tumors by immunohistochemistry with mutation-specific antibodies
    Meeting Abstract

    Wen, Y. H.; Brogi, E.; Hasanovic, A.; Ladanyi, M.; Soslow, R.; Shia, J.; Moreira, A. L.
    Histopathology (2012)

    Fulltext@MSK | Save